» Articles » PMID: 36945272

Correlation of T-regulatory Cells and Iron Status in β-Thalassemia Major Patients

Overview
Journal Cureus
Date 2023 Mar 22
PMID 36945272
Authors
Affiliations
Soon will be listed here.
Abstract

Background The increased risk of infections in transfusion-dependent β-thalassemia major (TDT) patients is mainly due to underlying immune dysfunction; however, its cause is largely unidentified. There is sufficient evidence to suggest immune changes due to iron deficiency; however, similar studies demonstrating the effects of iron excess on immune cells in these cases are limited. Aim and objectives To analyze the correlation between T-regulatory cells and iron stores in β-thalassemia major patients. Methods In this study, 20 β-thalassemia major cases and 20 healthy controls were studied for complete hemogram, iron profile, and flow cytometric immunophenotyping for CD3+, CD4+, CD8+, and T-regulatory cells markers (CD4+CD25+ and CD4+CD25+FOXP3+). Result Significantly higher levels of serum iron, ferritin, transferrin saturation, and CD4+ cell percentage were observed in cases than in controls. In 70% of cases with serum ferritin cut-off levels of less than 1000 µg/L, the T-regulatory cell marker CD4+CD25+ and serum ferritin revealed a significant moderate positive correlation (p=0.031, r=0.627). These same 70% cases also demonstrated a moderately significant positive correlation between serum iron and absolute lymphocyte count (r=0.529, p=0.042). Conclusion The results suggest that serum ferritin in excess amounts can increase T-regulatory cells, which may further alter the immune status of TDT patients; however, the absence of such a correlation in cases with serum ferritin of more than 1000 µg/L remains unanswered. It is important to understand immune system alterations as this will help provide new modalities for managing thalassemia patients in the form of immunoregulatory therapies.

References
1.
Atmakusuma T, Girson R, Koesnoe S . Correlations between Iron Load and CD4 in Adult Transfusion-Dependent Beta Thalassemia. Anemia. 2021; 2021:5549503. PMC: 8233081. DOI: 10.1155/2021/5549503. View

2.
Yadav S, Panchal P, Menon K . Prevalence and Management of β-Thalassemia in India. Hemoglobin. 2022; 46(1):27-32. DOI: 10.1080/03630269.2021.2001346. View

3.
Hagag A, Elgamsy M, El-Asy H, Gamal R, Elshahaby W, Abd Elbar E . Immune Status 'in Children with Beta Thalassemia' in Correlation 'with Iron Overload': Single Center Egyptian Study. Endocr Metab Immune Disord Drug Targets. 2016; 16(3):181-188. DOI: 10.2174/1871530317666161107160213. View

4.
Boer M, Joosten S, Ottenhoff T . Regulatory T-Cells at the Interface between Human Host and Pathogens in Infectious Diseases and Vaccination. Front Immunol. 2015; 6:217. PMC: 4426762. DOI: 10.3389/fimmu.2015.00217. View

5.
Shokrgozar N, Amirian N, Ranjbaran R, Bazrafshan A, Sharifzadeh S . Evaluation of regulatory T cells frequency and FoxP3/GDF-15 gene expression in β-thalassemia major patients with and without alloantibody; correlation with serum ferritin and folate levels. Ann Hematol. 2020; 99(3):421-429. DOI: 10.1007/s00277-020-03931-9. View